Innova Captab / Q3-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-02-10Back to INNOVACAPTAB

Revenue

₹450.3 Cr

verified against source

Revenue YoY

42.3%

reported change

EBITDA

₹71.1 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q3 FY26: 42.1 · Positive source sentiment · 2026-02-10Q3 FY2642.142.1
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Innova Captab delivered a stellar Q3 FY26 with consolidated revenue surging 42.3% YoY to ₹450.3 crore, driven by strong performance across both CDMO (+29% YoY) and branded generics (+79% YoY). EBITDA grew 39.6% YoY to ₹71.1 crore, with margins at 15.8% (ex-Jammu ~19%). The Jammu facility contributed ₹89 crore revenue, nearing EBITDA breakeven, and is expected to turn PAT positive next year. Management guided for 20%+ overall growth in FY27, underpinned by Jammu ramp-up and continued branded generics expansion. Key risks include API price volatility and potential margin pressure from future growth investments.

Colored figures show movement against the previous available record.

Guidance to track

  • Management expects to maintain 20%+ year-on-year growth at the entity level in FY27, driven by Jammu ramp-up and branded generics expansion.
  • Jammu facility is on track to achieve ₹270-280 crore revenue for FY26, with potential to slightly exceed the range.
  • The Jammu facility is expected to contribute positively at both EBITDA and PAT levels in the next financial year.

Risks flagged

  • API prices have stabilized quarter-on-quarter but remain uncertain; year-on-year prices are still negative, and future trends are unpredictable.
  • Management indicated that future growth strategies may put pressure on P&L, potentially offsetting margin gains from Jammu.
  • Ex-Jammu CDMO volume growth was only 6-10% YoY, with revenue growth driven mainly by product mix rather than volume.

Key quotes

  • I am thrilled to report that Innova Captab delivered a stellar quarter with revenue from operations surging to 450 cr with a robust 42% year-on-year growth.
  • Jamu is nearing the break even at EBITDA level and ... in next year we are very much looking ahead to get a positive contribution from Jamu facility from both EBITDA as well as PAT level.
  • We always maintain our margin profile at say 15% plus minus 2% here and there ... businesses cannot be silent and we need to focus continuously on the future growth also.

Research modules

Go one layer deeper.